Delivery Order SPE2DB22D2206-SPE2DB25FDU67
Award Date
10/16/24
Potential Completion Date
11/6/24
Potential Value
$12K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,504.62 firm fixed-price delivery order is for the supply of TECENTRIQ 840 MG/14 ML VIAL 14ML, a specialty pharmaceutical product. The contract has an ultimate completion date of February 3, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $8,016.30, is for the delivery of Tecentriq 840 mg/14 ml vials. It is a firm fixed-price delivery order contract with a completion date of December 6, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, the Corporate Office division of parent company Cencora, Inc. The $8,016.30 fixed-price delivery order is for the supply of TECENTRIQ 840 MG/14 ML VIAL 14ML, a pharmaceutical product. The award supports the DLA's mission to provide logistics and acquisition services to the U.S. Armed Forces and other government agencies. Amerisourcebergen, a major pharmaceutical distributor, holds a...
This federal contract award, valued at $7,857.74, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a Delivery Order under an Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp. The $17,009.24 firm fixed-price delivery order is for the pharmaceutical product TECENTRIQ 840 MG/14 ML VIAL 14ML. The award is not associated with a set-aside designation. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying medical products to federal...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corporation's Corporate Office Division. The $16,032.60 firm fixed-price delivery order is for the supply of 840 mg/14 ml vials of the drug Tecentriq. The contract has an ultimate completion date of August 21, 2024 and was awarded on July 31, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $12,594.50, is a delivery order for the supply of Tecentriq Hybreza 1,875 mg 15 ml, a pharmaceutical product. The contract has an ultimate completion date of April 3, 2025 and a firm fixed price pricing type. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $34,018.40 contract is for the supply of 840 mg/14 ml vials of the cancer medication Tecentriq. The delivery order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with DLA Troop Support Medical to provide a wide range of pharmaceutical products and medical supplies in support of military...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of TECENTRIQ HYBREZA 1,875 MG 15ML, a medical product, with a ceiling value of $6,297.24 and a period of performance ending on July 16, 2025. The contract is a firm-fixed-price delivery order, with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp...
This federal contract award was made by the Defense Logistics Agency (DLA), a component of the U.S. Department of Defense (DoD), to Amerisourcebergen Drug Corp, a subsidiary of the pharmaceutical distribution company Amerisourcebergen Corporation. The $30,840.00 firm-fixed-price delivery order is for the supply of 4565122493 ! IMFINZI 500 MG/10 ML VIAL 10ML, a pharmaceutical product. This award is not designated as a set-aside contract. Amerisourcebergen Drug Corp holds a single-award Indefinite...